HK1246649A1 - 柠檬酸铁在治疗缺铁性贫血中的用途 - Google Patents
柠檬酸铁在治疗缺铁性贫血中的用途 Download PDFInfo
- Publication number
- HK1246649A1 HK1246649A1 HK18106104.0A HK18106104A HK1246649A1 HK 1246649 A1 HK1246649 A1 HK 1246649A1 HK 18106104 A HK18106104 A HK 18106104A HK 1246649 A1 HK1246649 A1 HK 1246649A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- iron
- deficiency anemia
- patients
- colitis
- ferric citrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562127963P | 2015-03-04 | 2015-03-04 | |
| US62/127,963 | 2015-03-04 | ||
| PCT/US2016/020575 WO2016141124A1 (en) | 2015-03-04 | 2016-03-03 | Use of ferric citrate in the treatment of iron-deficiency anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1246649A1 true HK1246649A1 (zh) | 2018-09-14 |
Family
ID=56848619
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18106104.0A HK1246649A1 (zh) | 2015-03-04 | 2016-03-03 | 柠檬酸铁在治疗缺铁性贫血中的用途 |
| HK18108472.0A HK1248589A1 (zh) | 2015-03-04 | 2016-03-03 | 柠檬酸铁在治疗缺铁性贫血中的用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18108472.0A HK1248589A1 (zh) | 2015-03-04 | 2016-03-03 | 柠檬酸铁在治疗缺铁性贫血中的用途 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180071243A1 (enExample) |
| EP (1) | EP3265077A4 (enExample) |
| JP (2) | JP2018507260A (enExample) |
| KR (1) | KR20170123664A (enExample) |
| CN (1) | CN107530310A (enExample) |
| AU (1) | AU2016226250B2 (enExample) |
| BR (1) | BR112017018963A2 (enExample) |
| CA (1) | CA2978073A1 (enExample) |
| EA (1) | EA201791960A1 (enExample) |
| HK (2) | HK1246649A1 (enExample) |
| IL (1) | IL254125A0 (enExample) |
| MX (1) | MX2017011169A (enExample) |
| SG (1) | SG11201707120PA (enExample) |
| TW (2) | TW202302083A (enExample) |
| WO (1) | WO2016141124A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102573807A (zh) | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| JP7387435B2 (ja) * | 2017-09-19 | 2023-11-28 | 日本たばこ産業株式会社 | 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用 |
| FR3075601A1 (fr) * | 2017-12-21 | 2019-06-28 | Clarisse Le Court | Complements alimentaires et leur utilisation sur les menstruations |
| WO2020247935A1 (en) * | 2019-06-07 | 2020-12-10 | Arizona Board Of Regents On Behalf Of Arizona State University | Body fluid iron level panel analyzer |
| WO2022251563A1 (en) | 2021-05-27 | 2022-12-01 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
| WO2023047424A1 (en) * | 2022-04-29 | 2023-03-30 | West Bengal Chemical Industries Limited | Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof |
| KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8093423B2 (en) * | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| WO2005067970A1 (ja) * | 2004-01-14 | 2005-07-28 | Gekkeikan Sake Co., Ltd. | 鉄補給剤及びその利用 |
| JP4931352B2 (ja) * | 2004-01-14 | 2012-05-16 | 月桂冠株式会社 | 鉄補給剤及びその利用 |
| JP5667343B2 (ja) * | 2005-08-18 | 2015-02-12 | パニオン アンド ビーエフ バイオテック インコーポレーテッド | 医薬グレードの第二鉄有機化合物、その使用およびその製造方法 |
| US20120288531A1 (en) * | 2011-01-14 | 2012-11-15 | Shmuel Tuvia | pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
| EA201590062A1 (ru) * | 2012-06-21 | 2016-02-29 | Керикс Байофармасьютикалз, Инк. | Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью |
-
2016
- 2016-03-03 CA CA2978073A patent/CA2978073A1/en not_active Abandoned
- 2016-03-03 TW TW111133966A patent/TW202302083A/zh unknown
- 2016-03-03 WO PCT/US2016/020575 patent/WO2016141124A1/en not_active Ceased
- 2016-03-03 CN CN201680025431.0A patent/CN107530310A/zh active Pending
- 2016-03-03 KR KR1020177027533A patent/KR20170123664A/ko not_active Ceased
- 2016-03-03 EP EP16759457.1A patent/EP3265077A4/en not_active Ceased
- 2016-03-03 SG SG11201707120PA patent/SG11201707120PA/en unknown
- 2016-03-03 BR BR112017018963A patent/BR112017018963A2/pt not_active Application Discontinuation
- 2016-03-03 MX MX2017011169A patent/MX2017011169A/es unknown
- 2016-03-03 EA EA201791960A patent/EA201791960A1/ru unknown
- 2016-03-03 AU AU2016226250A patent/AU2016226250B2/en not_active Expired - Fee Related
- 2016-03-03 HK HK18106104.0A patent/HK1246649A1/zh unknown
- 2016-03-03 HK HK18108472.0A patent/HK1248589A1/zh unknown
- 2016-03-03 US US15/553,348 patent/US20180071243A1/en not_active Abandoned
- 2016-03-03 JP JP2017564757A patent/JP2018507260A/ja active Pending
- 2016-03-03 TW TW105106564A patent/TWI812580B/zh active
-
2017
- 2017-08-23 IL IL254125A patent/IL254125A0/en unknown
-
2021
- 2021-01-26 JP JP2021010151A patent/JP2021091686A/ja active Pending
-
2022
- 2022-12-21 US US18/069,555 patent/US20240075006A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL254125A0 (en) | 2017-10-31 |
| CN107530310A (zh) | 2018-01-02 |
| JP2018507260A (ja) | 2018-03-15 |
| KR20170123664A (ko) | 2017-11-08 |
| US20240075006A1 (en) | 2024-03-07 |
| US20180071243A1 (en) | 2018-03-15 |
| AU2016226250A1 (en) | 2017-09-28 |
| TWI812580B (zh) | 2023-08-21 |
| WO2016141124A1 (en) | 2016-09-09 |
| SG11201707120PA (en) | 2017-09-28 |
| MX2017011169A (es) | 2017-11-09 |
| AU2016226250B2 (en) | 2021-05-27 |
| EA201791960A1 (ru) | 2018-01-31 |
| TW202302083A (zh) | 2023-01-16 |
| EP3265077A1 (en) | 2018-01-10 |
| BR112017018963A2 (pt) | 2018-05-15 |
| EP3265077A4 (en) | 2018-10-24 |
| TW201639558A (zh) | 2016-11-16 |
| HK1248589A1 (zh) | 2018-10-19 |
| CA2978073A1 (en) | 2016-09-09 |
| JP2021091686A (ja) | 2021-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1246649A1 (zh) | 柠檬酸铁在治疗缺铁性贫血中的用途 | |
| BR112019008384A2 (pt) | composição farmacêutica, processos para tratamento e seus usos | |
| JO3709B1 (ar) | تركيبة صيدلانية أو مجموعة طبية للاستخدام في علاج سرطان لدى كائن ثديي تتضمن إنزيم الأسباراجيناز وإنزيم الميثيونيناز | |
| SG10201906400SA (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| WO2015148389A3 (en) | Diagnosis of multiple sclerosis in human and animal subjects | |
| PH12020550462A1 (en) | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | |
| MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
| WO2015051135A3 (en) | Organic compositions to treat hepcidin-related diseases | |
| EP4279925A3 (en) | Dulaglutide for the treatment of chronic kidney disease | |
| IL287676A (en) | Treatment of kidney disease in patients with kidney and/or urinary tract anomalies | |
| EP4027815A4 (en) | COMPOSITIONS CONTAINING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED OF THEM | |
| JP2017061488A5 (enExample) | ||
| CN107148277A (zh) | 一种抑制脂肪细胞分化和胰岛素耐受的药物 | |
| WO2019232203A3 (en) | Methods and compositions to alleviate vascular permeability | |
| Habibian | Comparision of therapeutic effect of osveral & desferal in patients with thalassemia (Bahonar Hospital in Karaj 2012-2013) | |
| Caliskan et al. | Surgical management of endoscopic retrograde cholangiopancreatography related injuries | |
| Mabuchi et al. | Recurrent cerebral infarctions in a patient with ovarian cancer: a fatal case of Trousseau’s syndrome | |
| Au | Subcutaneous nodular sarcoidosis: case report | |
| Ullery | Aspirin/clopidogrel/warfarin | |
| McCarthy | Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds | |
| 이상헌 et al. | Endoscopic Resection for Rectal Carcinoid Tumors: Comparision of Polypectomy and Endoscopic Submucosal Resection with Band Ligation | |
| Durleshter et al. | Endoscopic transpapillary interventions in diagnostics and treatment of patients with diseases of the pancreatobiliary area | |
| Sykovatykh et al. | State of crural perforating veins after sclerosurgical interventions for lower limb varicose disease | |
| 李天润 | Intervention combined surgery for the treatment of acute iliofemoral vein thrombosis | |
| 정일형 | A Case of Successful Colonoscopic Treatment of Acute Appendiceal Bleeding by Endoclips |